tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Yatin Suneja, 135 are a BUY (83.85%), 26 are a HOLD (16.15%).
Analyst Yatin Suneja, currently employed at GUGGENHEIM, carries an average stock price target met ratio of 41.37% that have a potential upside of 33.11% achieved within 186 days.
Yatin Suneja’s has documented 370 price targets and ratings displayed on 41 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on ANAB, AnaptysBio at 12-Dec-2024.
Analyst best performing recommendations are on IMVT (IMMUNOVANT ).
The best stock recommendation documented was for IMVT (IMMUNOVANT ) at 9/22/2023. The price target of $32 was fulfilled within 4 days with a profit of $11.61 (56.94%) receiving and performance score of 142.35.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$27
$10.06 (59.39%)
$27
1 months 13 days ago
(07-Nov-2024)
8/22 (36.36%)
$9.79 (56.89%)
119
Buy
$28
$11.06 (65.29%)
$28
1 months 13 days ago
(07-Nov-2024)
0/4 (0%)
$10.79 (62.70%)
Hold
2 months 10 days ago
(10-Oct-2024)
11/14 (78.57%)
$9.98 (39.89%)
141
Buy
$23
$6.06 (35.77%)
$30
4 months 12 days ago
(08-Aug-2024)
0/3 (0%)
$7.28 (46.31%)
Buy
$20
$3.06 (18.06%)
$28
4 months 13 days ago
(07-Aug-2024)
16/21 (76.19%)
$4.83 (31.84%)
184
Which stock is Yatin Suneja is most bullish on?
Which stock is Yatin Suneja is most reserved on?
What Year was the first public recommendation made by Yatin Suneja?
